Liver transplant evaluation determines whether a patient with severe or irreversible liver disease may benefit from transplantation. The assessment includes liver function testing, imaging, evaluation of other organ systems and screening for infections or other medical risks. Specialists review the patient's overall condition and suitability for transplantation.
Pre-liver transplant assessment includes detailed medical investigations and preparation before transplantation. Doctors evaluate the severity of liver disease, nutritional status, cardiac and kidney function, infections and other conditions that may influence transplant outcomes. The process helps determine eligibility and optimise the patient's health before surgery.
Post-liver transplant care focuses on monitoring liver function, preventing organ rejection and identifying complications after transplantation. Patients usually require lifelong immunosuppressive medication and regular medical follow-up. Specialists monitor medication levels, infection risks, metabolic health and the functioning of the transplanted liver.
Liver cirrhosis develops when prolonged liver injury causes significant scarring and changes in liver structure. Management aims to treat the underlying cause, prevent complications and monitor liver function. Patients with advanced cirrhosis may require assessment for transplantation, particularly when complications develop despite appropriate medical treatment.
Fatty liver disease occurs when excess fat accumulates in liver cells and may be associated with obesity, diabetes and other metabolic conditions. Treatment generally focuses on weight management, improved nutrition, physical activity and control of metabolic risk factors. Regular monitoring helps identify inflammation or progressive liver scarring.
Hepatitis B is a viral infection that can cause chronic liver inflammation, cirrhosis and an increased risk of liver cancer. Management includes blood tests, liver assessment and antiviral medication when indicated. Long-term monitoring is important because some patients may develop significant liver complications even without prominent symptoms.
Hepatitis C is a viral infection that primarily affects the liver and can cause progressive inflammation and scarring. Modern direct-acting antiviral medications can cure most infections. Treatment planning involves assessing viral infection, liver fibrosis, associated medical conditions and potential medication interactions, followed by testing to confirm treatment response.
Acute liver failure involves a rapid decline in liver function and can become life-threatening. It may result from infections, medication toxicity or other causes of severe liver injury. Management requires urgent specialist assessment, supportive treatment and monitoring for complications, with liver transplant evaluation when medically necessary.
Chronic liver disease refers to persistent liver damage caused by conditions such as viral hepatitis, metabolic liver disease, alcohol-related injury or autoimmune disorders. Treatment focuses on controlling the underlying cause, monitoring liver function and preventing complications. Patients with advanced disease may need specialised transplant assessment.
Alcohol-related liver disease develops when prolonged or excessive alcohol consumption damages the liver. Treatment includes complete alcohol abstinence, nutritional support, management of complications and medical monitoring. Patients with advanced liver disease may require multidisciplinary care, including addiction support and evaluation for transplantation when appropriate.
Autoimmune liver diseases develop when immune-related inflammation affects the liver or bile ducts. Conditions may include autoimmune hepatitis and primary biliary cholangitis. Treatment depends on the diagnosis and may involve immunosuppressive or disease-specific medication, regular liver function monitoring and management of progressive liver damage.
Portal hypertension occurs when blood pressure increases within the portal venous system, commonly because of advanced liver scarring. It can lead to enlarged veins, abdominal fluid accumulation and other serious complications. Management may include medication, endoscopic interventions and selected specialised procedures based on clinical findings.
Ascites is the abnormal accumulation of fluid within the abdominal cavity, often associated with advanced liver cirrhosis. Management may involve salt restriction, diuretic medication and drainage of abdominal fluid when necessary. Persistent or recurrent ascites requires careful evaluation of liver function and other complications.
Hepatic encephalopathy is a neurological complication of advanced liver disease that may cause confusion, behavioural changes and reduced consciousness. Management focuses on identifying triggering factors, reducing the accumulation of harmful substances and treating the underlying liver condition. Severe cases require urgent hospital assessment.
Liver cancer assessment involves evaluating suspicious liver lesions using imaging, blood tests and appropriate diagnostic investigations. Patients with chronic hepatitis or cirrhosis may require regular surveillance. Treatment options depend on tumour characteristics, liver function and overall health, often requiring multidisciplinary specialist evaluation.
Therapeutic plasma exchange removes and replaces part of the patient's plasma to reduce selected harmful circulating substances. In certain severe liver disorders, it may be considered as a specialised supportive treatment. Its use depends on the underlying condition, available evidence and careful assessment by an experienced medical team.